ArticleNature medicine2025
A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission.
Abstract read
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Nextstrain automates real-time phylogenetic analysis of open data for endemic and emerging pathogens.Bioinformatics (Oxford, England) · 2026Article
- A generalized lineage nomenclature for viral genomic epidemiology.Nature microbiology · 2026Article
- Monkeypox virus clade IIb isolate exhibits reduced virulence relative to clade IIa isolates in multiple murine models.Journal of virology · 2026Article
- From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.Journal of virology · 2026Review
- Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo.BMJ global health · 2026Article
- Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone.Nature medicine · 2026Article
- Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults.Nature communications · 2026Article
- Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025.Viruses · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors.
Christopher RuisHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.
Eddy LusamakiInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0000-0001-9795-0165
Aine O'TooleInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-8083-474X
James R OtienoHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-9790-2307
Rachel ColquhounInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.
Cornelius RoemerUniversity of Basel and SIB, Basel, Switzerland.
Tony Wawina-BokalangaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Olivier Tshiani-MbayaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Daan JansenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-4612-6891
Jean-Claude MakangaraInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0000-0002-1791-2247
Anurag AgrawalTrivedi School of Biosciences, Ashoka University, Sonipat, India.
Laith Jamal Abu-RaddadWeill Cornell Medicine-Qatar of Cornell University, Doha, Qatar.ORCID http://orcid.org/0000-0003-0790-0506
Steve Ahuka-MundekeInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Ahidjo AyoubaTransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.
Esam I AzharSpecial Infectious Agents Unit - BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Leon CalyVictorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Christian DrostenCharité Medical Center, Berlin, Germany.ORCID http://orcid.org/0000-0001-7923-0519
Nuno R FariaSchool of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Adeola FowotadeCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Ana HoxhaHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-8674-0397
Baoying HuangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Bette KorberLos Alamos National Laboratory, The New Mexico Consortium, Los Alamos, NM, USA.ORCID http://orcid.org/0000-0002-2026-5757
Olivier le Polain de WarouxHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.
Rosamund F LewisHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-7227-2545
Laurens LiesenborghsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0001-5616-8548
Nada M MelhemFaculty of Health Sciences, American University of Beirut, Beirut, Lebanon.ORCID http://orcid.org/0000-0002-5423-4908
Vincent J MunsterNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2288-3196
Dimie OgoinaBayelsa Medical University, Yenagoa, Nigeria.ORCID http://orcid.org/0000-0002-2098-6300
Bas B Oude MunninkErasmus Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0002-9394-1189
Joseph Sriyal Malik PeirisSchool of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, People's Republic of China.ORCID http://orcid.org/0000-0001-8217-5995
Gustavo PalaciosDepartment of Microbiology at the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Martine PeetersTransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.
Paola ResendeLaboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies (LVRE), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-2884-3662
Anne W RimoinDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-0662-9067
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh.
Yee-Sin LeoNational Centre for Infectious Diseases, Singapore, Singapore.ORCID http://orcid.org/0000-0003-4978-5825
Tadaki SuzukiDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Koen VercauterenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-1472-9938
Pragya YadavNational Institute of Virology, Indian Council of Medical Research, Pune, India.ORCID http://orcid.org/0000-0002-0861-7166
Maria D Van KerkhoveHealth Emergencies Programme, World Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-6135-0018
Richard NeherUniversity of Basel and SIB, Basel, Switzerland.ORCID http://orcid.org/0000-0003-2525-1407
Tulio de OliveiraCentre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.
David UlaetoDefence Science and Technology Laboratory, Salisbury, UK.
Placide Mbala-KingebeniInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0000-0003-1556-3570
Jason KindrachukDepartment of Medical Microbiology & Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID http://orcid.org/0000-0002-3305-7084
Marion P G KoopmansErasmus Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0002-5204-2312
Meera ChandUK Health Security Agency, London, UK.
Anne von GottbergNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-0243-7455
Lorenzo SubissiHealth Emergencies Programme, World Health Organization, Geneva, Switzerland. subissil@who.int.ORCID http://orcid.org/0000-0001-5147-575X
Andrew RambautInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK. a.rambaut@ed.ac.uk.ORCID http://orcid.org/0000-0003-4337-3707
Funding
World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
40731088What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.